The effectiveness of vaccination against measles, the leading cause of vaccine-preventable
deaths in infants globally, is greatly impacted by the level of maternal antibody to measles …

This paper reviews literature on passively transferred maternal antibodies against measles
in infants. The amount and decay of these antibodies can be a result of changing patterns in …

Objective To investigate the duration of the presence of maternal antibodies to measles in
infants. Design Prospective study (May 2006 to November 2008). Setting Five hospitals in …

Introduction Young infants are protected from measles infection by maternal measles
antibodies. The level of these antibodies at birth depends on the level of antibodies in the …

The decay of maternally derived antibodies to measles, mumps, and rubella viruses in Swiss
infants was studied in order to determine the optimal time for vaccination. A total of 500 …

Mass vaccination can change the epidemiological dynamics of infectious diseases. It may
result in a limited persistence of natural and vaccine-induced immunity and a higher mean …

Aim There are few reliable estimates of the half-lives of maternal antibodies to the antigens
found in the primary series vaccines. We aimed to calculate the half-lives of passively …

Introduction Most infants are born with immunity to measles through maternal antibodies
transferred in pregnancy, which decay over time. However, in measles elimination settings …

Aims In recent years, Europe has recorded an increase in the number of measles outbreaks
despite the implementation of vaccination into the National Immunization Programs. The …

Background. The age at which passively acquired antibodies are lost is critical to
determining the optimal age for measles vaccination. Little is known about the influence of …